Exchange Traded Concepts’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-35,324
Closed -$652K 1323
2024
Q4
$652K Buy
35,324
+1,689
+5% +$33K 0.01% 740
2024
Q3
$731K Sell
33,635
-3,831
-10% -$85.7K 0.02% 681
2024
Q2
$735K Sell
37,466
-7,664
-17% -$160K 0.02% 547
2024
Q1
$979K Buy
45,130
+8,059
+22% +$200K 0.03% 441
2023
Q4
$1.07M Sell
37,071
-1,193
-3% -$31.9K 0.03% 393
2023
Q3
$1.02M Buy
38,264
+1,892
+5% +$64.6K 0.03% 384
2023
Q2
$1.35M Sell
36,372
-8,855
-20% -$309K 0.03% 331
2023
Q1
$1.41M Sell
45,227
-10,561
-19% -$340K 0.04% 260
2022
Q4
$1.66M Buy
55,788
+7,506
+16% +$269K 0.05% 212
2022
Q3
$1.84M Buy
48,282
+17,390
+56% +$872K 0.06% 159
2022
Q2
$1.69M Sell
30,892
-7,320
-19% -$402K 0.05% 191
2022
Q1
$2.38M Buy
38,212
+6,038
+19% +$398K 0.05% 194
2021
Q4
$3.24M Sell
32,174
-2,965
-8% -$261K 0.06% 178
2021
Q3
$3.16M Sell
35,139
-5,141
-13% -$467K 0.08% 172
2021
Q2
$3.71M Buy
40,280
+10,858
+37% +$867K 0.12% 128
2021
Q1
$2.84M Sell
29,422
-7,310
-20% -$755K 0.11% 144
2020
Q4
$1.91M Buy
36,732
+14,793
+67% +$618K 0.09% 151
2020
Q3
$878K Buy
+21,939
New +$687K 0.05% 181

Other funds holding FLGT

Exchange Traded Concepts's FLGT Position: Q1 2025 in Review

Exchange Traded Concepts sold out of Fulgent Genetics (FLGT) in Q1 2025, closing a stake of 35,324 shares — an estimated $652K sold.

Exchange Traded Concepts first reported a position in FLGT in Q3 2020 and held it in 18 quarters. The position peaked at $3.71M in Q2 2021. 176 funds tracked by Wall St. Rank hold FLGT as of Q1 2025.

  • Exchange Traded Concepts reported no remaining Fulgent Genetics position as of Q1 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 35,324 Fulgent Genetics shares in Q1 2025, an estimated $652K.
  • Exchange Traded Concepts first reported a position in Fulgent Genetics in Q3 2020 and held it in 18 quarters.
  • Exchange Traded Concepts's Fulgent Genetics position peaked at $3.71M in Q2 2021.
  • 176 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2025.

Based on Exchange Traded Concepts's 13F filing for Q1 2025, filed 17 Apr 2025.